Biotech · Private company
Enterin Inc.
Track this companyFree. Adds Enterin Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials40 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- Active Investigational Treatment ENT-01Phase 2 · ConstipationClinicalTrials.gov · fetched Nov 12, 2026
- Active Investigational Treatment ENT-01Phase 2 · Parkinson DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- ENT-01Phase 2 · Parkinson's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- A Study to Evaluate ENT-01 for the Treatment of Parkinson's Disease DementiaPHASE1 · WITHDRAWN · started Mar 1, 2024ClinicalTrials.gov NCT03938922 · fetched Nov 12, 2026
- Orally Administered ENT-01 for Parkinson's Disease-Related Constipation Follow-on Safety "Roll-over" Study (Rollover)PHASE2 · TERMINATED · started Jul 30, 2020ClinicalTrials.gov NCT04483479 · fetched Nov 12, 2026
- Orally Administered ENT-01 for Parkinson's Disease-Related Constipation (KARMET)PHASE2 · COMPLETED · started Dec 10, 2018ClinicalTrials.gov NCT03781791 · fetched Nov 12, 2026
- Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related ConstipationPHASE1_PHASE2 · COMPLETED · started May 11, 2017ClinicalTrials.gov NCT03047629 · fetched Nov 12, 2026